Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global Zoledronic Acid For Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

new_biaoQian Zoledronic Acid For Injection

According to our (Global Info Research) latest study, the global Zoledronic Acid For Injection market size was valued at USD 168.7 million in 2023 and is forecast to a readjusted size of USD 237.1 million by 2030 with a CAGR of 5.0% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Zoledronic Acid For Injection Supply, Demand and Key Producers, 2023-2029

date 20 Feb 2023

date Pharma & Healthcare

new_biaoQian Zoledronic Acid For Injection

The global Zoledronic Acid For Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Zoledronic Acid For Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 01 Jan 2023

date Pharma & Healthcare

new_biaoQian Zoledronic Acid For Injection

Zoledronic acid is a third-generation bisphosphonate compound developed by Novartis for the treatment of osteoporosis, osteitis deformans (Paget's disease of bone), bone metastases, multiple myeloma and tumour-induced hypercalcaemia.

USD3480.00

Add To Cart

Add To Cart

industry 09 Jan 2024

industry Pharma & Healthcare

new_biaoQian Zoledronic Acid For Injection

According to our (Global Info Research) latest study, the global Zoledronic Acid For Injection market size was valued at USD 168.7 million in 2023 and is forecast to a readjusted size of USD 237.1 million by 2030 with a CAGR of 5.0% during review period.

USD3480.00

addToCart

Add To Cart

industry 20 Feb 2023

industry Pharma & Healthcare

new_biaoQian Zoledronic Acid For Injection

The global Zoledronic Acid For Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 01 Jan 2023

industry Pharma & Healthcare

new_biaoQian Zoledronic Acid For Injection

Zoledronic acid is a third-generation bisphosphonate compound developed by Novartis for the treatment of osteoporosis, osteitis deformans (Paget's disease of bone), bone metastases, multiple myeloma and tumour-induced hypercalcaemia.

USD3480.00

addToCart

Add To Cart